A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus

[1]  V. Lemmens,et al.  Trends in incidence, treatment and survival of borderline ovarian tumors in the Netherlands: a nationwide analysis , 2019, Acta oncologica.

[2]  R. Klein,et al.  Genetic markers of pigmentation are novel risk loci for uveal melanoma , 2016, Scientific Reports.

[3]  S. Roman-Roman,et al.  Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage , 2016, Nature Communications.

[4]  Marko Hočevar,et al.  Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma , 2015, Nature Genetics.

[5]  J. Ioannidis,et al.  Updated field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma: the MelGene database. , 2015, The Journal of investigative dermatology.

[6]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[7]  A. Olszewski,et al.  Epidemiology and survival outcomes of ocular and mucosal melanomas: A population‐based analysis , 2014, International journal of cancer.

[8]  S. Thorgeirsson,et al.  CLPTM1L promotes growth and enhances aneuploidy in pancreatic cancer cells. , 2014, Cancer research.

[9]  M. You,et al.  CRR9/CLPTM1L regulates cell survival signaling and is required for Ras transformation and lung tumorigenesis. , 2014, Cancer research.

[10]  S. Zupo,et al.  Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma , 2014, British Journal of Cancer.

[11]  David Gentien,et al.  SF3B1 mutations are associated with alternative splicing in uveal melanoma. , 2013, Cancer discovery.

[12]  A. Hinnebusch,et al.  Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3 , 2013, Nature Genetics.

[13]  A. Bowcock,et al.  Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma , 2013, Nature Genetics.

[14]  Ivana K. Kim,et al.  Epidemiology and management of uveal melanoma. , 2012, Hematology/oncology clinics of North America.

[15]  D. Duffy,et al.  Human pigmentation genes under environmental selection , 2012, Genome Biology.

[16]  K. Coombes,et al.  Functional Characterization of CLPTM1L as a Lung Cancer Risk Candidate Gene in the 5p15.33 Locus , 2012, PloS one.

[17]  L. Cerroni,et al.  A Distinct Subset of Atypical Spitz Tumors is Characterized by BRAF Mutation and Loss of BAP1 Expression , 2012, The American journal of surgical pathology.

[18]  Ludwig A. Hothorn,et al.  Nonparametric Evaluation of Quantitative Traits in Population-Based Association Studies when the Genetic Model is Unknown , 2012, PloS one.

[19]  F. Clavel-Chapelon,et al.  Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma , 2012, Nature Genetics.

[20]  M. Swami.  New from NPG: Genome-wide association study identifies three new melanoma susceptibility loci , 2011, Nature Medicine.

[21]  M. Abdel-Rahman,et al.  Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers , 2011, Journal of Medical Genetics.

[22]  Arun D. Singh,et al.  Uveal melanoma: trends in incidence, treatment, and survival. , 2011, Ophthalmology.

[23]  J. Becker,et al.  Germline mutations in BAP1 predispose to melanocytic tumors , 2011, Nature Genetics.

[24]  E. Barillot,et al.  High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients. , 2011, Cancer research.

[25]  A. Bowcock,et al.  Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas , 2010, Science.

[26]  J. O'Brien,et al.  Mutations in GNA11 in uveal melanoma. , 2010, The New England journal of medicine.

[27]  William Wheeler,et al.  A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci , 2010, Nature Genetics.

[28]  Wolfgang Viechtbauer,et al.  Conducting Meta-Analyses in R with the metafor Package , 2010 .

[29]  Wei Zheng,et al.  A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33 , 2010, Nature Genetics.

[30]  M. Dimatteo,et al.  A Meta-Analysis , 2009 .

[31]  P. Donnelly,et al.  Designing Genome-Wide Association Studies: Sample Size, Power, Imputation, and the Choice of Genotyping Chip , 2009, PLoS genetics.

[32]  Paolo Vineis,et al.  Sequence variants at the TERT-CLPTM1L locus associate with many cancer types , 2009, Nature Genetics.

[33]  E. Simpson,et al.  Frequent somatic mutations of GNAQ in uveal melanoma and blue nevi , 2008, Nature.

[34]  Christopher I Amos,et al.  Common 5p15.33 and 6p21.33 variants influence lung cancer risk , 2008, Nature Genetics.

[35]  Simon Heath,et al.  Lung cancer susceptibility locus at 5p15.33 , 2008, Nature Genetics.

[36]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[37]  Helena Brentani,et al.  Gene Expression Profile Associated with Response to Doxorubicin-Based Therapy in Breast Cancer , 2005, Clinical Cancer Research.

[38]  A. Okamoto,et al.  A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. , 2001, Biochemical and biophysical research communications.

[39]  M. Tucker,et al.  CDKN2A mutations in multiple primary melanomas. , 1998, The New England journal of medicine.

[40]  D. Strickland,et al.  Melanomas of eye: stability of rates. , 1981, American journal of epidemiology.

[41]  David M. Thomas,et al.  Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. , 2014, Human molecular genetics.

[42]  K. Hemminki,et al.  Variants at chromosome 20 (ASIP locus) and melanoma risk , 2013, International journal of cancer.

[43]  O. Delaneau,et al.  Supplementary Information for ‘ Improved whole chromosome phasing for disease and population genetic studies ’ , 2012 .

[44]  C. Shields,et al.  The association between host susceptibility factors and uveal melanoma: a meta-analysis. , 2006, Archives of ophthalmology.

[45]  N. Hayward,et al.  Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma , 1996, Nature Genetics.

[46]  M. Feldman,et al.  Supporting Online Material Materials and Methods Figs. S1 to S3 Tables S1 to S5 References Worldwide Human Relationships Inferred from Genome-wide Patterns of Variation , 2022 .

[47]  D. Schadendorf,et al.  Highly Recurrent TERT Promoter Mutations in Human Melanoma , 2022 .